Skip to content

Long-term Outcomes After Different Management Strategies for High-level Cerebral Arteriovenous Malformation

Study on the Long-term Outcomes of High-level Cerebral Arteriovenous Malformation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04136860
Acronym
OHAVM
Enrollment
1000
Registered
2019-10-23
Start date
2012-04-01
Completion date
2024-12-31
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriovenous Malformation of Brain

Brief summary

Arteriovenous malformations (AVMs) are complex and rare cerebral vascular dysplasia. The main purpose of treatment is to avoid the neurological impairment caused by hemorrhagic stroke. The Spetzler-Martin (SM) grading system is widely used to estimate the risk of postoperative complication based on maximum AVM nidus diameter, pattern of venous drainage, and eloquence of location. Generally, grade I and II are amenable to surgical resection alone. Grade III is typically treated via a multimodal approach, including microsurgical resection, embolization, and radiosurgery (SRS). Grade IV and V are generally observed unless ruptured. However, some previous studies indicated that despite the high rate of poor outcomes for high-level unruptured AVMs, the mortality for high-level unruptured AVMs are likely lower than untreated patients. With the development of new embolic materials and new intervention strategies, patients with high-level AVMs may have more opportunities to underwent more aggressive interventions. The OHAVM study aims to clarify the clinical outcomes for patients with SM grade IV and V AVMs after different management strategies.

Detailed description

Follow-up: In our neurosurgical center, follow-up was conducted for all patients at the first 3-6 months and annually after discharge by clinical visit and telephone interview. Study overview: The population in the OHAVM study will be divided into two parts. Clinical and imaging data of high-level AVM patients from 2012/04 to 2019/09 were retrospectively collected. And the high-level AVM patients from 2019/09 to 2019/12 were prospectively collected. The intervention strategies in our institution for high-level AVMs are of four categories: microsurgical resection, embolization, embolization+radiosurgery, and single-stage hybrid surgery (embolization-resection). Each participants will be followed at least for 5 year since enrollment. Finally, we will clarify the clinical outcomes and prognostic predictors for patients with SM grade IV and V AVMs after different management strategies. Sample size: About 1000 patients will be enrolled in this study, and half of them were unruptured. The population distribution of different management strategies is expected as follows: conservative:100 cases, microsurgical resection: 300 cases, embolization:250 cases, embolization+radiosurgery: 250 cases, single-stage hybrid surgery: 100 cases. Study endpoints: The neurological function prognosis, occlusion rate and complications were evaluated at 2 weeks, 1 year, 3 years, 5 years after the treatment and the last follow-up, respectively.

Interventions

None listed

Sponsors

Peking University International Hospital
CollaboratorOTHER
Beijing Tiantan Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. The diagnosis of AVM was confirmed with digital subtraction angiography (DSA) and/or magnetic resonance imaging(MRI). 2. The SM grade was IV and V.

Exclusion criteria

1. Patients with multiple AVMs. 2. Patients with hereditary hemorrhagic telangiectasia (HHT). 3. Patients with missing clinical and imaging data.

Design outcomes

Primary

MeasureTime frameDescription
Long-term hemorrhagic rateConservative group: from the diagnosis to the last follow-up (up to 10 years); Intervention group: from 2 weeks after the operation to the last follow-up (up to 10 years)For conservative group, the observation period was from the diagnosis to the last follow-up. For the intervention group, to rule out the influence of transient unstable blood flow in the perioperative period, the observation period was defined as from 2 weeks after the operation to the last follow-up.
modified Ranking Scale score at 2 weeks after the operation2 weeks after operationThe scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. 1. No significant disability. Able to carry out all usual activities, despite some symptoms. 2. Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. Moderate disability. Requires some help, but able to walk unassisted. 4. Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. Dead
modified Ranking Scale score at 1 year after the operation1 year after operationThe scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. 1. No significant disability. Able to carry out all usual activities, despite some symptoms. 2. Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. Moderate disability. Requires some help, but able to walk unassisted. 4. Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. Dead
modified Ranking Scale score at 3 years after the operation3 years after operationThe scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. 1. No significant disability. Able to carry out all usual activities, despite some symptoms. 2. Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. Moderate disability. Requires some help, but able to walk unassisted. 4. Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. Dead
modified Ranking Scale score at 5 years after the operation5 years after the operationThe scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. 1. No significant disability. Able to carry out all usual activities, despite some symptoms. 2. Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. Moderate disability. Requires some help, but able to walk unassisted. 4. Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. Dead
modified Ranking Scale score at the last follow-upup to 10 years after the operationThe scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. 1. No significant disability. Able to carry out all usual activities, despite some symptoms. 2. Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. Moderate disability. Requires some help, but able to walk unassisted. 4. Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. Dead

Secondary

MeasureTime frameDescription
Obliteration rateAt least 3 years, up to 10 yearsConfirmed by postoperative DSA or MRI/MRA

Other

MeasureTime frameDescription
Incidence of endovascular embolization injury2 weeks after the operationEndovascular embolization injuries include arterial dissection, catheter failure, etc.
Incidence of postoperative epilepsy2 weeks and 1 years after the operation and the last follow-up (up to 10 years)It can only be diagnosed as postoperative epilepsy with the evidence of typical convulsions and other systemic seizures or EEG evidence.
Incidence of perioperative hemorrhage2 weeks after the operationBleeding within two weeks after the operation may be related to the redistribution of cerebral blood flow. The diagnosis of perioperative hemorrhage requires CT confirmation.
Incidence of perioperative infarction2 weeks after the operationPerioperative infarction within two weeks after the operation may be related to the redistribution of cerebral blood flow. The diagnosis of perioperative infarction requires CT confirmation or MRI confirmation.
Incidence of radiation necrosisHalf a year and 1 years after the operation and the last follow-up (up to 10 years)Radiation necrosis usually starts to appear within half a year after gamma knife operation. MRI evidence is needed to diagnose radiation necrosis.

Countries

China

Contacts

Primary ContactYu Chen, MD
chenyu_tiantan@126.com8618801239327
Backup ContactYuanli Zhao, MD
zhaoyuanli@126.com86-010-59978478

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026